好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Transient Ischemic Attack Presenting as Alien Hand Syndrome
Cerebrovascular Disease and Interventional Neurology
(-)
241
Authors/Disclosures
Anthony J. Vaughn, MD, FAAN (Mercy Health Center) No disclosure on file
Tania Reyna, MD, FAAN (University of Texas at San Antonio) Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics .
Aaron K. Farrow, MD (Mercy Clinic Neurology) No disclosure on file
Calin I. Prodan, MD (Univ of Oklahoma - Neurology Dept) The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.